Evidence map›Paper›PMID 25252960›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers.

Chetna Soni, Eric B Wong, Phillip P Domeier, Tahsin N Khan, Takashi Satoh, Shizuo Akira, Ziaur S M Rahman

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 1 synthesis or guideline pooled it, 167 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Unraveled role of TLR7-mediated interferon signaling activation in COVID-19.Frontiers in cellular and infection microbiology · 2025
    Review
  20. Review

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Chetna SoniDepartment of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, PA 17033;
Eric B WongDepartment of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, PA 17033;
Phillip P DomeierDepartment of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, PA 17033;
Tahsin N KhanDepartment of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, PA 17033; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239; and.
Takashi SatohDepartment of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Shizuo AkiraDepartment of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Ziaur S M RahmanDepartment of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey, PA 17033; zrahman@hmc.psu.edu.
Pennsylvania State University · USOsaka University · JPOregon Health & Science University · US

Funding

"Perturbation of peripheral B cell tolerance by the lupus susceptibility loci"R01AI091670 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI RAHMAN, ZIAUR · 2011 to 2015
$1.9M
NIAID NIH HHS AI091670NIAID NIH HHS R01 AI091670
6 · The paper itself

Abstract

Spontaneous germinal center (Spt-GC) B cells and follicular helper T cells generate high-affinity autoantibodies that are involved in the development of systemic lupus erythematosus. TLRs play a pivotal role in systemic lupus erythematosus pathogenesis. Although previous studies focused on the B cell-intrinsic role of TLR-MyD88 signaling on immune activation, autoantibody repertoire, and systemic inflammation, the mechanisms by which TLRs control the formation of Spt-GCs remain unclear. Using nonautoimmune C57BL/6 (B6) mice deficient in MyD88, TLR2, TLR3, TLR4, TLR7, or TLR9, we identified B cell-intrinsic TLR7 signaling as a prerequisite to Spt-GC formation without the confounding effects of autoimmune susceptibility genes and the overexpression of TLRs. TLR7 deficiency also rendered autoimmune B6.Sle1b mice unable to form Spt-GCs, leading to markedly decreased autoantibodies. Conversely, B6.yaa and B6.Sle1b.yaa mice expressing an extra copy of TLR7 and B6.Sle1b mice treated with a TLR7 agonist had increased Spt-GCs and follicular helper T cells. Further, TLR7/MyD88 deficiency led to compromised B cell proliferation and survival after B cell stimulation both in vitro and in vivo. In contrast, TLR9 inhibited Spt-GC development. Our findings demonstrate an absolute requirement for TLR7 and a negative regulatory function for TLR9 in Spt-GC formation under nonautoimmune and autoimmune conditions. Our data suggest that, under nonautoimmune conditions, Spt-GCs initiated by TLR7 produce protective Abs. However, in the presence of autoimmune susceptibility genes, TLR7-dependent Spt-GCs produce pathogenic autoantibodies. Thus, a single copy of TLR7 in B cells is the minimal requirement for breaking the GC-tolerance checkpoint.

Indexed as

Signal TransductionAnimalsAntibody FormationAutoantibodiesAutoimmunityB-LymphocytesCell SurvivalDendritic CellsFemaleGene ExpressionGerminal CenterHumansImmunohistochemistryImmunophenotypingLymphocyte ActivationMaleAutoantibodiesToll-Like Receptor 7Toll-Like Receptor 9

Identifiers

PMID25252960
PMCPMC4201954
OpenAlexW2147449671

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.